Log in to your Inderes Free account to see all free content on this page.
Dicot Pharma
0.29 SEK
+0.52 %
Less than 1K followers
DICOT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Dicot Pharma
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | 0.2 | |||||
| growth-% | 91.7 % | ||||||
| EBITDA | -13.3 | -17.5 | -27.2 | -31.7 | -45.0 | -59.3 | -82.4 |
| EBIT | -13.3 | -17.5 | -27.2 | -31.7 | -45.0 | -59.3 | -82.4 |
| Profit before taxes | -13.4 | -17.5 | -27.2 | -31.8 | -44.2 | -57.7 | -80.2 |
| Net income | -13.4 | -17.5 | -27.2 | -31.8 | -44.2 | -57.7 | -80.2 |
| EPS | -0.32 | -0.29 | -0.25 | -0.13 | -0.06 | -0.05 | -0.04 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -26,433.3 % | -19,565.2 % | |||||
| EBIT-% | -26,433.3 % | -19,569.6 % | |||||
| ROE | -104.6 % | -89.2 % | -95.9 % | -592.5 % | -99.5 % | -51.7 % | -109.3 % |
| ROI | -95.2 % | -81.2 % | -85.5 % | -256.8 % | -82.5 % | -46.7 % | -93.8 % |
Login required
This content is only available for logged in users